If you're having trouble viewing this email, see it on the Web.
Technet21

Home | Invite Others | Digest Archives  

Posts:

technet21 postspacerSIGN Meeting 2009: HCWM Presentations (I)

technet21 postspacerWHO Position Paper on Rotavirus Vaccines: Update

Issue 39, 25 January 2010

 
Editorial Note

Issue 39 includes a selection of the presentations made on Healthcare Waste Management at the 2009 SIGN meeting. In addition, Jhilmil Bhal sends us the latest version of the WHO position paper on rotavirus

There has been not a single response to the request for images that could be used in the TechNet21 Digest. So sending the request out again this week. The image size should be at least 300 x 500 pixels with a resolution of around 72 dpi. Image formats could be JPG/Tiff. Thank you.


The annual meeting of the Safe Injection Global Network (SIGN) was held from 30 November to 2 December 2009. The following are some of the presentations on Healthcare Waste Management:

  1. HCWM--10 Years: Yves Chartier
  2. PATH's Work in HCWM
  3. Resource Mobilization for Effective Waste Management: Ruma Tavorath
  4. Electronic Monitoring Tool for HCWM: Nancy Mueller
  5. Assessment and Formulation of a Strategy on HCWM: Ute Pieper

[Read more]

Comment on this post by email or on the web


by Erin Sparrow

Please note that an update to WHO's position paper on rotavirus vaccines published in 2007 (see http://www.who.int/wer/2007/wer8232.pdf) has been published in the WHO Weekly Epidemiological Record in English and French —see http://www.who.int/wer/ 2009/wer8451_52.pdf. The Arabic, Chinese, Russian and Spanish translations of the document will be posted on http://www.who.int/immunization/documents/ positionpapers/en/index.html in due course.

Key recommendations from the update are as follows:
WHO recommends that rotavirus vaccine for infants should be included in all national immunization programmes. In countries where diarrhoeal deaths account for ≥10% of mortality among children aged <5 years, the introduction of the vaccine is strongly recommended. WHO recommends that the first dose of either RotaTeq or Rotarix be administered at age 6–15 weeks. The maximum age for administering the last dose of either vaccine should be 32 weeks.

[Read more]

Comment on this post by email or on the web

Photo Courtesy: Markku Toryalai Hart

Web Highlights:
 
technet21 post

Global cervical cancer market to grow up to $4.1 billion by 2016

  technet21 post

Vi typhoid vaccine is highly effective in young children

  technet21 post

Prompt vaccination reduces chickenpox risk after exposure

  technet21 post

Support tools for evidence-informed health policymaking

  technet21 post

Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine

 


Register

If you have contributions to make or thoughts to share with others on TechNet21, you can write to the moderator or post directly on the web forums. Click here to change your subscription settings or unsubscribe from the mailing list.

TechNet21 is generously supported by the Bill and Melinda Gates Foundation, under the oversight of WHO and UNICEF. The information in this forum is provided by users, as a service. All contributions are reviewed prior to posting, and all postings are attributed to the authors. The details given in emails will not be voluntarily shared or sold to any outside company and will only be used for verification and to identify postings, if necessary. The authors are solely responsible for their submissions, and the readers are solely responsible for the interpretation of these submissions. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to this forum.

For posts where the author is a WHO staff member, the author alone is reponsible for the views expressed and they do not necessarily represent the decisions, guidelines, recommendations or policies of WHO.